Biogen/Samsung Bioepis

Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B

medications

The future of pharmacovigilance: Assessing the role of ML, NLP and other technologies

Laboratory image

Data breaches targeting pharma companies are ‘rampant,’ report says

What’s really happening with clinical trial innovation?

Kyverna

Kyverna Therapeutics wins $85 million in Series B financing

Leyden Labs

Leyden Labs closes $140M in Series B funding

Pfizer-BioNTech

Pfizer and BioNTech test omicron-specific COVID-19 vaccine in adults

Verana Health

Verana Health aims to go deep with its real-world data network

Gilead logo

FDA extends approval of remdesivir to encompass non-hospitalized high-risk